What Happens When You Stop GLP-1
FDA-approved pharmacotherapy alternatives include several options with established safety profiles: Semaglutide (Wegovy): A GLP-1 receptor agonist producing 12-15% weight loss, with cardiovascular benefits demonstrated in the SELECT trial and FDA-approved indication for reducing cardiovascular risk Liraglutide (Saxenda): A GLP-1 receptor agonist producing 5-8% weight loss [4] Phentermine-topiramate (Qsymia): FDA-approved combination producing 7-10% weight loss with established safety data Naltrexone-bupropion (Contrave): Combination targeting reward pathways and appetite, producing 5-9% weight loss [4] Orlistat (Xenical, Alli): Lipase inhibitor producing 3-5% weight loss with gastrointestinal side effects [4] Setmelanotide (Imcivree): For rare genetic obesity disorders (POMC, PCSK1, LEPR deficiency) [4] Metabolic and bariatric surgery should be considered for patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities who have not achieved adequate weight loss with nonsurgical interventions
External resources For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Plus, a healthier lifestyle can decrease risk and reduce symptoms for many lifestyle related conditions including: Heart disease Stroke Dementia Metabolic syndrome insulin resistance and diabetes Hypertension Dyslipidemia Kidney disease Gut issues Accomplish Your Goals Your experience at the Pritikin Center is a life-changing opportunity to work with a team of health experts to finally lose weight for good
Although experts acknowledge an association, hair loss on semaglutide is probably caused not by the drug itself but by prolonged caloric restriction and a lack of essential hair-health nutrients like protein and keratin
Given the current limited literature, GLP-1 agonists should generally be avoided during pregnancy if possible
